Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 08:10:59 +0200Thu, 06 Jun 2024 13:13:00 +0200Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 45, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tysabriHuman medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 45, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tysabriThu, 06 Jun 2024 13:13:00 +0200Human medicineTysabri : EPAR - All authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/h-603-aa_en.pdfTysabri : EPAR - All authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/h-603-aa_en.pdfTue, 06 Apr 2021 16:09:00 +0200Human medicine